endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news
Ken Takeshita, Daiichi Sankyo global head of R&D

En­her­tu strikes again with a PhI­II suc­cess in an­oth­er breast can­cer pop­u­la­tion

An­oth­er sum­mer day, an­oth­er En­her­tu up­date.

The As­traZeneca-Dai­ichi Sankyo an­ti­body-drug con­ju­gate has passed an­oth­er tri­al, this time a Phase III tri­al test­ing the can­cer drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA